A significant business delegation from the Nigerian pharmaceutical industry is set to engage in discussions with Indian manufacturers and exporters in New Delhi from September 5 to 10, 2023, with the aim of forging potential joint ventures...
Pharmaceutical companies are poised to sustain their growth and profitability, with the United States playing a central role in their expansion, reports India Ratings and Research (Ind-Ra). The industry's upward trajectory will be fueled by product..
Cipla South Africa, a division of Cipla Limited, has agreed to buy Actor Pharma, a prominent player in the South African over-the-counter (OTC) market, in order to increase its presence in the country's healthcare sector...
AstraZeneca’s Calquence , a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)...
Samir Desai, President of BU Biologics and Vaccines at Zydus Life Sciences, advocates for collaborative partnerships between pharmaceutical companies and healthcare practitioners to extend vaccinations beyond pediatric age groups to encompass...
LISSUN, one of India’s largest mental health platforms, has raised $1.3 million in a seed round led by Inflection Point Ventures (IPV) & Rainmatter Capital (Zerodha Group). The round also saw participation from existing investors...
Pharmaceutical industry leaders in South India are urging the Union health ministry to prioritize the proper maintenance of pharmacies and strengthen the distribution channel before enforcing generic prescription mandates....
The pharmaceutical industry in Gujarat, India, is experiencing a remarkable growth trajectory, with a 40% increase in the past four years. As of March 2023, the industry's annual turnover stands at Rs 1.42 lakh crore, and it is poised to achieve...
The Ministry of Ayush has stated that, subject to certain criteria, Ayurveda, Siddha, and Unani (ASU) manufacturing facilities can be used to manufacture food products licenced by the Food Safety & Standards Authority of India (FSSAI)....
Procter & Gamble (P&G) plans to invest Rs. 2,000 crore in its premium psyllium husk-based laxative drug product and Rs. 200 crore in its Vicks range of products in Gujarat as part of its domestic and global business expansion, according to Gujarat..
, CDSCO.jpg)
.jpg)